Comments*

 
  • Cancer & Signaling Discussion Group

    Cancer research has revealed that complex systems of molecular pathways drive tumor formation. By understanding these pathways, scientists hope to identify molecular targets within them that would be receptive to drugs in ways that could interrupt cancer progression.

    The Cancer & Signaling Discussion Group provides a forum for exploring the molecular networks that ensure proper cell cycle progression, and how alterations in these networks modulate gene expression, cause mutations, and lead to carcinogenesis. Meetings of the group focus on specific themes related to signal transduction dysregulation in oncogenesis, and cover basic, clinical, and diagnostic aspects of the field.

  • Events

    Tuesday, November 16, 2010 | 1:00 PM - 5:00 PM

    Non-coding RNAs in Oncogenesis

    Speakers: Greg Hannon (Cold Spring Harbor Laboratory), Pier Paolo Pandolfi (Harvard Medical School), John Rinn (Harvard Medical School), Ramin Shiekhattar (The Wistar Institute), David Spector (Cold Spring Harbor Laboratory)

    Non- coding RNAs are emerging as important regulators of development and function in many physiological processes. Their role in controlling pathogenesis and their potential as targets for therapeutic intervention are becoming increasingly apparent.

  • Steering Commitee

    David Epstein, PhD

    OSI Pharmaceuticals

    Senthil Muthuswamy, PhD

    Cold Spring Harbor Laboratory

    Pier Paolo Pandolfi, MD, PhD

    Harvard Medical School

    Nicholas Tonks, PhD

    Cold Spring Harbor Laboratory

    George Zavoico, PhD

    MLV

    Asher Zilberstein, PhD

    Sanofi-Aventis


  • Sponsors

    • Sanofi
    • OSI

    Mission Partner support for the Frontiers of Science program provided by:

    • Johnson & Johnson

    Get more information about how you can sponsor a discussion group.

    EmailPrint